Investigation of Tenascin Expression in Endometriosis

Table 1

Serum and tissue levels of tenascin.

	Group 1; (𝑛=15)	Group 2; (𝑛=30)	𝑃 value
Serum tenascin (ng/mL)
(i) Proliferative phase	41 ± 7	38 ± 8.5	0.73
(ii) Secretory phase	39 ± 9	36 ± 9	0.95
Eutopic endometrial tenascin; (pg/mg)
(i) Proliferative phase	30 ± 9	33 ± 14	0.93
(ii) Secretory phase	319 ± 109	311 ± 127	0.71
Ectopic endometrial tenascin; (pg/mg)
(i) Proliferative phase	—	32 ± 11	—
(ii) Secretory phase	—	285 ± 100	—

Note: The results are presented as mean ± SD.